💨 Abstract

In May 2025, a 23-year-old medical student experienced severe weakness and speech difficulties, leading to a diagnosis of a rare, aggressive brain tumor (glioblastoma). Despite years of unexplained symptoms, doctors had dismissed them as stress or sleep-related. The tumor was partially removed through surgery, followed by radiotherapy and chemotherapy. However, the tumor spread, and the student sought cutting-edge immunotherapy in Germany, funded by a public fundraiser started by his sisters.

Courtesy: Alex Warwick